Spiezia investigated 530 patients with DVT for the principal thrombophilias (antithrombin, proteins C and S deficiencies, lupus anticoagulant, factor V Leiden, and prothrombin G20210A mutation) [33]. The gene discussed is F2; the disease is deep vein thrombosis.